In Vitro Susceptibility of Leishmania infantum to Artemisinin Derivatives and Selected Trioxolanes
Leishmaniasis is among the world's most neglected diseases. Currently available drugs for treatment present drawbacks, urging the need for more effective, safer, and cheaper drugs. A small library of artemisinin-derived trioxanes and synthetic trioxolanes was tested against promastigote and int...
Saved in:
Published in | Antimicrobial agents and chemotherapy Vol. 59; no. 8; pp. 5032 - 5035 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Society for Microbiology
01.08.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Leishmaniasis is among the world's most neglected diseases. Currently available drugs for treatment present drawbacks, urging the need for more effective, safer, and cheaper drugs. A small library of artemisinin-derived trioxanes and synthetic trioxolanes was tested against promastigote and intramacrophage amastigote forms of Leishmania infantum. The trioxolanes LC50 and LC95 presented the best activity and safety profiles, showing potential for further studies in the context of leishmanial therapy. Our results indicate that the compounds tested exhibit peroxide-dependent activity. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 S.C., A.A., and L.I.L.C. contributed equally to this work. Citation Cortes S, Albuquerque A, Cabral LIL, Lopes L, Campino L, Cristiano MLS. 2015. In vitro susceptibility of Leishmania infantum to artemisinin derivatives and selected trioxolanes. Antimicrob Agents Chemother 59:5032–5035. doi:10.1128/AAC.00298-15. |
ISSN: | 0066-4804 1098-6596 |
DOI: | 10.1128/AAC.00298-15 |